Using Randomization Tests to Address Disruptions in Clinical Trials: A Report from the NISS Ingram Olkin Forum Series on Unplanned Clinical Trial Disruptions
STATISTICS IN BIOPHARMACEUTICAL RESEARCH(2023)
Abstract
Recent examples for unplanned external events are the global COVID-19 pandemic, the war in Ukraine, or most recently Hurricane Ian in Puerto Rico. Disruptions due to unplanned external events can lead to violation of assumptions in clinical trials. In certain situations, randomization tests can provide nonparametric inference that is robust to violation of the assumptions usually made in clinical trials. The ICH E9 (R1) Addendum on estimands and sensitivity analyses provides a guideline for aligning the trial objectives with strategies to address disruptions in clinical trials. In this article, we embed randomization tests within the estimand framework to allow for inference following disruptions in clinical trials in a way that reflects recent literature. A stylized clinical trial is presented to illustrate the method, and a simulation study highlights situations when a randomization test that is conducted under the intention-to-treat principle can provide unbiased results.
MoreTranslated text
Key words
Bias,Clinical trial design,COVID-19,Estimand,Intercurrent event,Randomization based inference
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined